eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Special issues Subscription
SCImago Journal & Country Rank

 
3/2009
vol. 5
 
Share:
Share:
more
 
 
abstract:

Review paper
Role of cyclooxygenase-2 in cervical cancer

Małgorzata Klimek
,
Krzysztof Urbański
,
Zbigniew Kojs
,
Kazimierz Karolewski
,
Jacek Pudełek
,
Paweł Blecharz

Arch Med Sci 2009; 5, 3: 303-307
Online publish date: 2009/10/22
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Concurrent radiation and chemotherapy is a standard treatment of patients with cervical cancer in FIGO stages IB2-IVA. Chemotherapy given in the same time as irradiation improved survival significant, but not involves all patients. Cancer recurrence is the most common treatment failure in patients with advanced tumor. Further improvement in the treatment of advanced cases is essential. The increasing knowledge about new biologic markers and better ability to predict risk of cancer recurrence is very important for construction of more effective treatment strategies. Currently, there is considerable interest of role of cyclooxgenase-2 in cervical neoplasia. A lot of cancers in different localizations appear to overexpress the cyclooxygenase-2, which may have an important role in carcinogenesis. Ongoing clinical trials, clinical studies have shown the positive therapeutic effect of COX-2 inhibitors and may allow to increase understanding of this novel targeted approach for cervical cancer control.
keywords:

cervical cancer, radiochemotherapy, cyclooxygenase-2

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe